BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-6.35%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11.4B
AUM Growth
+$11.4B
(-6.4%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
87.68%
Holding
125
New
6
Increased
22
Reduced
9
Closed
4
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$245M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$99.8M |
| 3 |
Ascendis Pharma
ASND
|
$11.1M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$10.3M |
| 5 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$5.96M |
Top Sells
| 1 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$69.3M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$14.2M |
| 3 |
Exelixis
EXEL
|
$12.8M |
| 4 |
Neurocrine Biosciences
NBIX
|
$12.8M |
| 5 |
Cerus
CERS
|
$7.06M |
Sector Composition
| 1 | Healthcare | 92.57% |
